FEDERAL COURT RULES IN ICAN’S FAVOR AND ORDERS COVID-19 SAFETY DATA TO BE DISCLOSED

After months of NIH objecting, and after seeking Court intervention, ICAN’s attorneys have won a motion which now forces the NIH to unredact and disclose safety-related data they tried to withhold from Moderna’s Phase 1 clinical trial report. As a result of a FOIA request, the National Institutes of Health (NIH) provided ICAN a copyContinue reading “FEDERAL COURT RULES IN ICAN’S FAVOR AND ORDERS COVID-19 SAFETY DATA TO BE DISCLOSED”